SS-31 10mg (Elamipretide)
Size: 10mg | 99% Purity
nM.Wt: 639.80
nFormula: C32H49N9O5
nSolubility: H2O
nPurity: >99%
nStorage: -20°C / 3 years
nHalf life: Not established
nCAS No.: 736992-21-5
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 639.80 g/mol |
| Molecular formula | C32H49N9O5 |
| CAS number | 736992-21-5 |
| Synonyms | Elamipretide, MTP-131, Bendavia, D-Arg-2′6′-Dmt-Lys-Phe-NH2 |
| Solubility | H2O |
| Storage | '-20°C / 3 years |
| Half-life | Not established |
Peptide sequence
D-Arg-Dmt-Lys-Phe-NH2
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 10 mg)
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
SS-31 10mg (Elamipretide) — research reference material
n
SS-31 10mg (Elamipretide) is supplied by ADIPHEX as a research reference material in a 10mg presentation. Compound class: Mitochondrial-targeted tetrapeptide · Elamipretide, characterised in the literature as a mitochondrial peptide. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
n
Research context
n
Mitochondria-targeted; studied in cardiolipin, mito-protection. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our SS-31 research reference. Related compounds in the same research area: MOTS-c, NAD+, Reduced Glutathione. You can also compare it side by side on our comparison tool.
n
Presentation
n
This listing is the 10mg presentation at >99% stated purity, catalogue reference SS3110.
n
Identifiers
n
- n
- CAS number: 736992-21-5
- Molecular formula: C32H49N9O5
- Molecular weight: 639.80 g/mol
- Synonyms: Elamipretide, MTP-131, Bendavia, D-Arg-2′6′-Dmt-Lys-Phe-NH2
- Class: Mitochondrial-targeted tetrapeptide · Elamipretide
n
n
n
n
n
n
Format & quality
n
Supplied as 10mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
n
Storage
n
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch.
n
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. ADIPHEX supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
n
Frequently asked questions
n
What is SS-31 10mg (Elamipretide)?
n
Mitochondrial-targeted tetrapeptide · Elamipretide. Mitochondria-targeted; studied in cardiolipin, mito-protection. ADIPHEX supplies it as a research reference material only.
n
What is the CAS number for SS-31 10mg (Elamipretide)?
n
736992-21-5. Molecular formula C32H49N9O5. Molecular weight 639.80 g/mol.
n
How should SS-31 10mg (Elamipretide) be stored?
n
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
n
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.
Tung C et al. · International journal of molecular sciences · 2025
PubMed PMID 39940712 -
Elamipretide: First Approval.
Shirley M et al. · Drugs · 2026
PubMed PMID 41335372 -
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Zhao W et al. · Journal of neuroinflammation · 2019
PubMed PMID 31747905
You may also need
